Velandia-Martínez A, Ortega-Sanchez MA, Martínez-Perez SO, Peña I, Pradilla O, Gomez R, Martínez-Perez A. Parry-Romberg Syndrome and Temporal Lobe Refractory Epilepsy: Case Report.
J Epilepsy Res 2019;
9:157-160. [PMID:
32509553 PMCID:
PMC7251345 DOI:
10.14581/jer.19020]
[Citation(s) in RCA: 2] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/05/2018] [Revised: 01/13/2020] [Accepted: 01/24/2020] [Indexed: 11/05/2022] Open
Abstract
The Parry-Romberg syndrome (PRS), also known as hemifacial atrophy, is a rare neurocutaneous disease with the prevalence of 1/700,000 cases. It is more common in women than men, with an early onset of disease usually within the first two decades of life. Even though the etiology of PRS is unknown, it is thought to be a multifactorial disease that involves hereditary, posttraumatic, autoimmune, infectious, and neoplastic factors. There are a variety of systemic manifestations described in PRS including neurological conditions that range from intractable headache to refractory epilepsy. The manifestations must be identified in a timely manner to ensure an early therapeutic intervention, considering that an appropriate approach during the initial phase might halt the disease progression and markedly improve the quality of life in these patients. This article is aimed to describe the case of a 23 years old female with left hemifacial atrophy and dermatologic, dental, and neurologic compromise, associated with refractory temporal lobe epilepsy evidenced in neuroimaging and electrodiagnostic testings.
Collapse